Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,073,549,493
-$62,853,173 QoQ
Shares Held
8,164,545
-6.6% QoQ
Ownership
0.339%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#37
of 4,647 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Research Global Investors holds $40,525,577,269 across 9 Drug Manufacturers - General names. JNJ ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,873,140 | $25,035,872,397 | |
| 2 | ABBV |
AbbVie Inc.
|
30,101,551 | $7,574,754,293 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
19,393,296 | $2,450,149,016 | |
| 4 | AMGN |
Amgen Inc
|
6,272,625 | $2,271,442,965 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
8,164,545 | $2,073,549,493 | |
| 6 | AZN |
Astrazeneca PLC
|
4,197,587 | $795,946,446 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,925,013 | $247,364,170 | |
| 8 | SNY |
Sanofi
|
1,677,399 | $71,557,841 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,073,549,493 | 8,164,545 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,136,402,666 | 8,739,988 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $593,907,179 | 2,869,810 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $558,990,680 | 3,014,727 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $517,432,529 | 3,387,447 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $407,538,035 | 2,457,417 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $354,871,448 | 2,453,820 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $185,086,133 | 1,142,084 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $166,788,730 | 1,141,138 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $100,630,670 | 636,138 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $99,657,643 | 635,815 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $99,033,014 | 635,846 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $137,014,476 | 827,782 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $128,249,480 | 827,416 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $295,102,834 | 1,670,551 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $272,901,211 | 1,670,551 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $146,828,639 | 827,157 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $146,636,380 | 827,379 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $141,536,475 | 827,360 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $133,649,971 | 827,554 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $136,302,581 | 827,380 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $235,176,796 | 1,430,951 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $225,204,012 | 1,430,957 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $321,005,229 | 2,156,134 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $303,275,767 | 2,156,551 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $289,440,101 | 2,207,276 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||